Drug Profile
Research programme: alpha-7 nicotinic acetylcholine receptor agonists - Pfizer
Alternative Names: CP-810,123; PHA 785454; PHA-543613E; PHA-568487; PHA-758454; PNU-120596; PNU-282987Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Pfizer
- Class Small molecules
- Mechanism of Action Alpha7 nicotinic acetylcholine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Schizophrenia in USA (PO)
- 05 Aug 2009 This programme is in active development
- 21 Aug 2008 PHA 758454 identified as a lead candidate